West St. Paul Fogging Scheduled Amid High West Nile Virus Risk

Manitoba Health, Seniors and Long-Term Care announced an additional round of adult mosquito control in the Rural Municipality of West St. Paul, scheduled for the weekend of August 21, 2026, following surveillance data that revealed high counts of Culex tarsalis mosquitoes and an elevated West Nile virus infection rate. The targeted intervention aims to mitigate ongoing transmission risks as provincial health officials track four human cases of the virus across Manitoba so far in 2026.

• Manitoba Health scheduled a third round of fogging in West St. Paul using DeltaGard 20EW following surveillance data showing high Culex tarsalis infection rates.
• The province has reported one confirmed case and three probable human cases of West Nile virus across multiple health regions for the 2026 season.
• Health Canada classifies DeltaGard 20EW as a reduced-risk pesticide that poses minimal threat to human health when applied via ultra-low volume methods per label directions.

Surveillance Data and Public Health Intervention

According to surveillance data from Manitoba Health, Seniors and Long-Term Care, the ongoing intervention in West St. Paul is authorized under an existing ministerial order issued in July 2026. The order permits provincial fogging operations targeting Culex tarsalis vectors in specific high-risk communities, including parts of Winnipeg. Previous spraying cycles in West St. Paul occurred on July 31 and August 7, 2026.

Provincial data systems indicate that average Culex tarsalis trap counts in the rural municipality more than doubled to 701 for the week ending August 8, 2026, though that figure marked a decline from 1,229 traps recorded two weeks prior. Across all provincial health regions, average mosquito counts per trap trended lower overall, with 60 West Nile virus-positive pools detected by mid-August. Despite the broader downward trend in trap counts, regional infection rates in West St. Paul remained high enough to trigger the ministerial order for an additional round of adult mosquito control.

Epidemiology of 2026 Human Cases in Manitoba

Manitoba Health confirmed a total of four human cases of West Nile virus for the 2026 season, comprising one confirmed case and three probable cases. The single confirmed case was localized within the Prairie Mountain Health region in western Manitoba. Meanwhile, the three probable cases appeared in the Interlake-Eastern and Southern Health regions. Clinical presentation of West Nile virus infection can range from asymptomatic seroconversion to severe neurological disease, including encephalitis (swelling of the brain), long-term neurological complications, and death.

Properties and Safety Profile of DeltaGard 20EW

The vector control initiative utilizes DeltaGard 20EW, an insecticide approved by Health Canada in 2017. Health Canada classifies the formulation as a reduced-risk pesticide. According to provincial statements, the compound is applied using ultra-low volume spraying methods strictly in accordance with product label directions, rendering it unlikely to affect human health.

Public health authorities emphasize that a single bite from an infected Culex tarsalis mosquito is sufficient to transmit the pathogen. To minimize exposure risks while awaiting seasonal temperature drops, provincial health guidance advises individuals to:

• Reduce time spent outdoors during peak vector activity hours between dusk and dawn.
• Apply appropriate mosquito repellents containing authorized active ingredients.
• Wear light-coloured, loose-fitting clothing featuring long sleeves and pant legs.
• Verify that door and window screens fit tightly and remain free of structural holes.
• Eliminate standing water sources around residential properties to disrupt breeding cycles.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.